跳至主要内容
临床试验/IRCT20221018056238N1
IRCT20221018056238N1招募中2 期

Evaluation of efficacy of treatment with lisdexamphetamine (vyas) in comparison with extended release methylphenidate (sandoz) on improving the quality of life and executive function of adults with attention deficit hyperactivity disorder : an open-lable randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 56 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 no limit(—)
性别
All

入选标准

  • Age more than 16 years
  • Diagnosis of adult attention deficit hyperactive disorder based on DSM-5
  • Diagnosis of adult attention deficit hyperactive disorder based on DIVA-5

排除标准

  • Alcohol and other substance us
  • History of Bipolar or psychotic disorders
  • Other psychiatric disorders such as MDD or Autism spectrum disorder
  • Pregnancy or Lactation
  • hypersensitivity to drugs used in this study
  • Neurologic disorders or severe Hepatic or Renal disease
  • BMI less than 18
  • Dependency to drugs ex. Benzodiazepines MDMA and other substances
  • History of not responding to stimulants
  • Use of any other drug with effects on CNS

研究者

相似试验